Pain during injection. Unspecified complication during therapeutic injection, transport and injection
Conditions
Interventions
Intervention 1: Drug: Ketamine
Dose: 0.1mg/kg IV Injection
Number of using: Once
Factory name: Rotexmedica
Manufacturing Country's name: Germany
Administration time: 45 seconds before Propofol admin
Treatment - Drugs
Placebo
Drug: Ketamine
Dose: 0.1mg/kg IV Injection
Number of using: Once
Factory name: Rotexmedica
Manufacturing Country's name: Germany
Administration time: 45 seconds before Propofol administration
Drug: Fentanil
Dose: 1mcg/kg IV Injection
Number of using: Once
Factory name: Chekad
Manufacturing Country's name: Iran
Administration time: 45 seconds before Propofol administration
Placebo: Normal Saline 0.9%
Dose used: 2 ml IV Injection
Number of using: Once
Factory name: Samen Pharmacy CO.
Manufacturing Country's name: Iran
Administration time: 45 seconds before Propo
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - The patient's satisfaction – Age between 20 and 60 years old. Exclusion criteria: - History of substance abuse; hypnotics or narcotics throughout 24 hours before the surgery - History of drug abuse, or alcohol- dependency - Contraindication of Propofol or Ketamine - High Intracranial Pressure
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain during propofol injection. Timepoint: Every 5 seconds after injection. Method of measurement: Verbal Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation. Timepoint: Every 5 seconds after injection. Method of measurement: Watching. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNushin Runassi
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed